Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in progressive MS
NCT05893225Phase 2Active, not recruiting
- Start
- Nov 2023
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in multiple sclerosis (MS). Started Nov 2023; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05893225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05893225.